AR009513A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME. - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME.

Info

Publication number
AR009513A1
AR009513A1 ARP970104005A ARP970104005A AR009513A1 AR 009513 A1 AR009513 A1 AR 009513A1 AR P970104005 A ARP970104005 A AR P970104005A AR P970104005 A ARP970104005 A AR P970104005A AR 009513 A1 AR009513 A1 AR 009513A1
Authority
AR
Argentina
Prior art keywords
coenzyme
treatment
pharmaceutical composition
useful
acquired immunodeficiency
Prior art date
Application number
ARP970104005A
Other languages
Spanish (es)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR009513A1 publication Critical patent/AR009513A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione

Abstract

Una composicion farmacéutica para el tratamiento del síndrome de inmunodeficiencia adquirida que comprende una coenzima elegida entre el NA yNADP y por lo menos un componente no activo farmacéuticamente aceptable.A pharmaceutical composition for the treatment of acquired immunodeficiency syndrome comprising a coenzyme chosen from NA and NADP and at least one pharmaceutically acceptable non-active component.

ARP970104005A 1996-09-06 1997-09-03 PHARMACEUTICAL COMPOSITION THAT INCLUDES A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME. AR009513A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001834A IT1284139B1 (en) 1996-09-06 1996-09-06 PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME

Publications (1)

Publication Number Publication Date
AR009513A1 true AR009513A1 (en) 2000-04-26

Family

ID=11374849

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104005A AR009513A1 (en) 1996-09-06 1997-09-03 PHARMACEUTICAL COMPOSITION THAT INCLUDES A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME.

Country Status (5)

Country Link
AR (1) AR009513A1 (en)
AU (1) AU4457897A (en)
IT (1) IT1284139B1 (en)
WO (1) WO1998009634A1 (en)
ZA (1) ZA976895B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401504B1 (en) * 2010-08-02 2013-07-26 Cattarini Mastelli COMPOSITION INCLUDING GLUTATION AND REDUCTASE AND OXIDIZED GLUTATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222419A (en) * 1983-05-31 1984-12-14 Sankyo Co Ltd Cholesterol-lowering agent
US5051353A (en) * 1988-08-09 1991-09-24 The United States Of America As Represented By The Secretary Of The Navy Preservation and restoration of hemoglobin in blood substitutes
FR2715303A1 (en) * 1991-04-02 1995-07-28 Berque Jean Riboflavin for treating human immunodeficiency virus related diseases
EP0638315B1 (en) * 1993-08-13 1998-11-18 Nikolai Vasilievich Karsanov Antihypoxic agent
FR2718353B3 (en) * 1994-04-11 1996-06-28 Jean Berque Pharmaceutical compositions based on non-toxic biological products intended for the local protection of the genital and rectal mucosa.

Also Published As

Publication number Publication date
WO1998009634A1 (en) 1998-03-12
IT1284139B1 (en) 1998-05-08
ITMI961834A1 (en) 1998-03-06
ZA976895B (en) 1998-02-18
AU4457897A (en) 1998-03-26

Similar Documents

Publication Publication Date Title
UY26296A1 (en) DRUG TREATMENT OF INQUIET LEGS SYNDROME
CO5170495A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
ATE486840T1 (en) MODIFIED FORMS OF PHARMACEUTICALLY ACTIVE AGENTS AND USES THEREOF
BG106030A (en) Pharmaceutical composition
CO5160320A1 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OF TOLERANCE TO MEDICINES DAS.
ES2162517T3 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND FIBRATE AND ITS USE IN THE PREPARATION OF DRUGS INTENDED TO REDUCE HYPERGLYCEMIA.
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
AR013117A1 (en) A SOLID PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET THAT INCLUDES A BENZOFURAN DERIVATIVE WITH ANTIARRHYTHMIC ACTIVITY ADAPTED FOR ORAL ADMINISTRATION
AU2855399A (en) Vascularization inhibitors
ES2091001T3 (en) CAPSULE CONTAINING A SUSCEPTIBLE DEGRADATION COMPONENT AND A COMPOSITE POLYMER.
BR0014312B1 (en) pharmaceutical composition containing a pharmaceutical combination comprising loteprednol and azelastine, medicament and its production process, and use of said combination.
ES2344356T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ETHYLESTRADIOL.
AR034813A1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
ECSP930933A (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR PREPARING IT
NO990440L (en) Preparation that includes mupirocin and chlorhexidine
CR6834A (en) COMPLEXES AND COMPOSITIONS OF MACROMOLECULAR DRUGS CONTAINING THE SAME
DE60102590D1 (en) PHARMACEUTICAL FORMS FOR TREATING ORAL MYCOSIS
UY25798A1 (en) PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE INCLUDING A THIAZOLIDINADIONIC INSULIN SENSITIZER.
HUP0002644A2 (en) Phartmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor
BR0113165A (en) 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods
PA8552301A1 (en) METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA
UY26171A1 (en) PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF LATE APPEARANCE DYSKINESIA
AR009513A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME.
AR034142A1 (en) A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION
UY25103A1 (en) COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS